The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

Abstract Background While the treatment guidelines have been established for pure urothelial carcinoma (pUC), patients with variant type urothelial carcinoma (vUC) face limited effective treatment options. The effectiveness of immune checkpoint inhibitors (ICI) in patients with vUC remains uncertain...

Full description

Bibliographic Details
Main Authors: Tsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, Ming-Chun Kuo, Chang-Ting Lin, Chia-Che Wu, Hao-Lun Luo, Chien-Hsu Chen, Chih-Chi Chou, Ting-Ting Liu, Chun-Chieh Huang, Kai-Lung Tsai, Yu-Li Su
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Cancer
Subjects:
Metastatic urothelial carcinoma
Variant histology
Immune checkpoint inhibitors
Real-world data
Online Access:https://doi.org/10.1186/s12885-023-11398-w

Internet

https://doi.org/10.1186/s12885-023-11398-w

Similar Items